This definitive contract was awarded by the National Institutes of Health National Cancer Institute to Massive Bio, Inc. for $399,594. The contract is associated with the National Institutes of Health and Centers for Disease Control and Prevention SBIR Phase I solicitation seeking proposals for research and development in support of cancer-related topics including clinical trials recruitment and retention tools for participant engagement. The contract will be performed in New York, New York from September 2020 through September 2021 under a firm fixed price structure. This total small business set-aside award furthers the National Cancer Institute's mission by developing tools to help engage participants in cancer clinical trials.
Generated 12/29/23, 2:32 PM